{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:02:36Z","timestamp":1795104156684,"version":"4.10.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the General Programs of Lianyungang Health and Planning Commission","award":["202027"],"award-info":[{"award-number":["202027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgroud<\/jats:title>\n                    <jats:p>\n                      The current diagnostic criteria for refractory\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (RMPP) among\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      Pneumonia (MPP) are insufficient for early identification, and potentially delayed appropriate treatment. This study aimed to develop an effective individualized diagnostic prediction nomogram for pediatric RMPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 517 hospitalized children with MPP, including 131 with RMPP and 386 without RMPP (non-RMPP), treated at Lianyungang Maternal and Child Health Care Hospital from January 2018 to December 2021 were retrospectively enrolled as a development (modeling) cohort to construct an RMPP prediction nomogram. Additionally, 322 pediatric patients with MPP (64 with RMPP and 258 with non-RMPP, who were treated at the Affiliated Hospital of Xuzhou Medical University from June 2020 to May 2022 were retrospectively enrolled as a validation cohort to assess the prediction accuracy of model. Univariable and multivariable logistic regression analyses were used to identify RMPP risk factors among patients with MPP. Nomogram were generated based on these risk factors using the rms package of R, and the predictive performance was evaluated based on receiver operating characteristic (ROC) curves and using decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariate analysis revealed five significant independent predictors of RMPP among patients with MPP: age (hazard ratio [\n                      <jats:italic>HR<\/jats:italic>\n                      ] 1.16, 95% confidence interval [\n                      <jats:italic>CI<\/jats:italic>\n                      ] 1.08\u20131.33,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.038), fever duration (\n                      <jats:italic>HR<\/jats:italic>\n                      1.34, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.20\u20131.50,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), lymphocyte count (\n                      <jats:italic>HR<\/jats:italic>\n                      0.45, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.23\u20130.89,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.021), serum D-dimer (D-d) level (\n                      <jats:italic>HR<\/jats:italic>\n                      1.70, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.16\u20132.49,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), and pulmonary imaging score (\n                      <jats:italic>HR<\/jats:italic>\n                      5.16, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      2.38\u201311.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The area under the ROC curve was 90.7% for the development cohort and 96.36% for the validation cohort. The internal and external verification calibration curves were almost linear with slopes of 1, and the DCA curve revealed a net benefit with the final predictive nomogram.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study proposes a predictive nomogram only based on five variables. The nomogram can be used for early identification of RMPP among pediatric patients with MPP, thereby facilitating more timely and effective intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02684-1","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:02:02Z","timestamp":1696939322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model"],"prefix":"10.1186","volume":"23","author":[{"given":"Meng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Quan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Ye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"2684_CR1","doi-asserted-by":"crossref","unstructured":"Wang Y, Liu K, Chen C, Zhang C. Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation. Ital J Pediatr. 2023;49(1):80.","DOI":"10.1186\/s13052-023-01491-y"},{"issue":"4","key":"2684_CR2","first-page":"317","volume":"61","author":"JH Liu","year":"2023","unstructured":"Liu JH, Liu JR, Tang XL, et al. Predictive factors for sequelae of bronchitis obliterans in refractory Mycoplasma pneumoniae pneumonia. Zhonghua Er Ke Za Zhi. 2023;61(4):317\u201321.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2684_CR3","doi-asserted-by":"crossref","unstructured":"Lee E, Kim C, Lee YJ, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132.","DOI":"10.1186\/s12879-020-4810-9"},{"issue":"3","key":"2684_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","volume":"57","author":"A Tamura","year":"2008","unstructured":"Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect. 2008;57(3):223\u20138.","journal-title":"J Infect"},{"issue":"17","key":"2684_CR5","first-page":"1304","volume":"30","author":"Pediatrics of Chinese Medical Association Branch of the Breathing Group","year":"2015","unstructured":"Pediatrics of Chinese Medical Association Branch of the Breathing Group, Chinese Journal of Applied Clinical Pediatrics Editorial Board. Expert consensus on diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2015). Chin J Appl Clin Pediatr. 2015;30(17):1304\u20138.","journal-title":"Chin J Appl Clin Pediatr"},{"key":"2684_CR6","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.2147\/JIR.S321656","volume":"14","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Zhang T, Zhu B, et al. Increasing age affected polymorphonuclear neutrophils in prognosis of mycoplasma pneumoniae pneumonia. J Inflamm Res. 2021;14:3933\u201343.","journal-title":"J Inflamm Res"},{"issue":"3","key":"2684_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2684_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1186\/s12879-021-06783-4","volume":"21","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Zhang H, Shang Y, Zhao Y, Zhang Y, Zhuang D, et al. Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model. BMC Infect Dis. 2021;21(1):1085.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"2684_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s12098-022-04205-0","volume":"89","author":"E Lee","year":"2022","unstructured":"Lee E, Choi I. Clinical usefulness of serum lactate dehydrogenase levels in mycoplasma pneumoniae pneumonia in children. Indian J Pediatr. 2022;89(10):1003\u20139.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"2684_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12879-020-05700-5","volume":"21","author":"X Huang","year":"2021","unstructured":"Huang X, Li D, Liu F, Zhao D, Zhu Y, Tang H. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2021;21(1):14.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2684_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10156-011-0265-7","volume":"17","author":"T Oishi","year":"2011","unstructured":"Oishi T, Uchiyama M, Oishi T, et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia. J Infect Chemother. 2011;17(6):803\u20136.","journal-title":"J Infect Chemother"},{"key":"2684_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/IDR.S240034","volume":"13","author":"J Zhao","year":"2020","unstructured":"Zhao J, Ji X, Wang Y, Wang X. Clinical role of serum interleukin-17A in the prediction of refractory mycoplasma pneumoniae pneumonia in children. Infect Drug Resist. 2020;13:835\u201343.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2684_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","volume":"25","author":"G Li","year":"2019","unstructured":"Li G, Fan L, Wang Y, et al. High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia. Mol Med. 2019;25(1):38.","journal-title":"Mol Med"},{"key":"2684_CR14","doi-asserted-by":"publisher","first-page":"9227838","DOI":"10.1155\/2022\/9227838","volume":"2022","author":"W Huang","year":"2022","unstructured":"Huang W, Xu X, Zhao W, Cheng Q. Refractory Mycoplasma pneumonia in children: a systematic review and meta-analysis of laboratory features and predictors. J Immunol Res. 2022;2022:9227838.","journal-title":"J Immunol Res."},{"issue":"8","key":"2684_CR15","doi-asserted-by":"publisher","first-page":"e0219463","DOI":"10.1371\/journal.pone.0219463","volume":"14","author":"YJ Cho","year":"2019","unstructured":"Cho YJ, Han MS, Kim WS, et al. Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia. PLoS One. 2019;14(8):e0219463.","journal-title":"PLoS One"},{"issue":"9","key":"2684_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/pathogens10091075","volume":"10","author":"SH Kim","year":"2021","unstructured":"Kim SH, Lee E, Song ES, Lee YY. Clinical significance of pleural effusion in mycoplasma pneumoniae pneumonia in children. Pathogens. 2021;10(9):1075.","journal-title":"Pathogens"},{"issue":"1","key":"2684_CR17","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1038\/s41598-021-86086-5","volume":"11","author":"Y Bi","year":"2021","unstructured":"Bi Y, Zhu Y, Ma X, et al. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children. Sci Rep. 2021;11(1):6595.","journal-title":"Sci Rep"},{"key":"2684_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","volume":"29","author":"M Wang","year":"2014","unstructured":"Wang M, Wang Y, Yan Y, et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. Int J Infect Dis. 2014;29:18\u201323.","journal-title":"Int J Infect Dis"},{"key":"2684_CR19","doi-asserted-by":"crossref","unstructured":"Choi YJ, Chung EH, Lee E, et al. Clinical characteristics of macrolide-refractory Mycoplasma pneumoniae pneumonia in Korean children: a multicenter retrospective study. J Clin Med. 2022;11(2):306.","DOI":"10.3390\/jcm11020306"},{"key":"2684_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcpa.2021.01.011","volume":"184","author":"F Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez F, Ram\u00edrez AS, Castro P, et al. Pathological and immunohistochemical studies of experimental Mycoplasma pneumoniae in Gerbils (Meriones unguiculatus). J Comp Pathol. 2021;184:37\u201343.","journal-title":"J Comp Pathol"},{"key":"2684_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12879-021-05830-4","volume":"21","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Zhang T, Guo W, et al. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021;21:126.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"2684_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejim.2011.10.019","volume":"23","author":"D Snijders","year":"2012","unstructured":"Snijders D, Schoorl M, Schoorl M, et al. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med. 2012;23(5):436\u201341.","journal-title":"Eur J Intern. Med"},{"key":"2684_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.687391","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Hua L, Zhao Q, et al. The Level of D-Dimer is positively correlated with the severity of Mycoplasma pneumoniae Pneumonia in children. Front Cell Infect Microbiol. 2021;11: 687391.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2684_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12879-020-05110-7","volume":"20","author":"B Zheng","year":"2020","unstructured":"Zheng B, Zhao J, Cao L. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children. BMC Infect Dis. 2020;20(1):391.","journal-title":"BMC Infect Dis"},{"key":"2684_CR25","doi-asserted-by":"crossref","unstructured":"Wen J, Su Y, Sun H, et al. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study. Resp Res. 2021;22(1):89.","DOI":"10.1186\/s12931-020-01577-9"},{"issue":"12","key":"2684_CR26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"M Morozumi","year":"2012","unstructured":"Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55(12):1642\u20139.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2684_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jiac.2019.01.003","volume":"25","author":"T Okumura","year":"2019","unstructured":"Okumura T, Kawada JI, Tanaka M, et al. Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect Chemother. 2019;25(5):346\u201350.","journal-title":"J Infect Chemother"},{"issue":"4","key":"2684_CR28","first-page":"340","volume":"73","author":"F Li","year":"2021","unstructured":"Li F, Zhu B, Xie G, Wang Y, Geng J. Effects of bronchoalveolar lavage on pediatric refractory mycoplasma pneumoniae pneumonia complicated with atelectasis: a prospective case-control study. Minerva Pediatr (Torino). 2021;73(4):340\u20137.","journal-title":"Minerva Pediatr (Torino)"},{"issue":"4","key":"2684_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.24684","volume":"55","author":"S Cheng","year":"2020","unstructured":"Cheng S, Lin J, Zheng X, et al. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2020;55(4):968\u201374.","journal-title":"Pediatr Pulmonol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02684-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:03:13Z","timestamp":1700301793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02684-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02684-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Lianyungang Maternal and Child Health Care Hospital (Protocol number LW2022003) and the Affiliated Hospital of Xuzhou Medical University (Protocol number XYFY2022-KL146-01). The ethics committee of Lianyungang Maternal and Child Health Care Hospital waived the need for written informed consent provided by participants due to retrospective study, because all patient data were analyzed anonymously, and no additional informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}